Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Wegovy is approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
10.1016/j.ebiom.2019.05.032 381 WeiW.JiangM.LuoL.LiZ.WangP.DongW
It targets GLP-1, GIP, and glucagon receptors, showing promising results for weight loss, blood sugar control, and overall metabolic health
A peer-reviewed study in the Journal of Endocrinology confirming that AOD9604 produces lipolysis and increases fat oxidation in obese mice via the beta-adrenergic pathway, with effects comparable to full-length HGH but without the insulin-disrupting side effects provided early mechanistic validation that informed the human trials
US$ 22.46
US$ 20.38
US$ 26.86
US$ 25.26
US$ 20.06
US$ 26.12
US$ 23.89
US$ 27.90
US$ 25.61
US$ 22.34
US$ 22.44
